Omontys (peginesatide) Injection, a drug used for anemia treatment in kidney dialysis patients, has been recalled because of "serious, life-threatening or fatal hypersensitivity reactions", including anaphylaxis. The voluntary recall has been announced by Takeda Pharmaceutical Co. and Affymax Inc. The two companies have recalled all Omontys lots which are sold in 20mg and 10mg vials. Doctors have been told not to administer the medication to patients...
via Health News from Medical News Today Read More Here..
No comments:
Post a Comment